Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 open-label study of ledipasvir/sofosbuvir in treatment-naive and treatment-experienced chronic genotype 1 HCV infection
CTR20160150Phase 3Completed
- Sponsor
- Gilead Sciences
- Start
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ledipasvir, sofosbuvir in chronic hepatitis C (CHC), sponsored by Gilead Sciences. Started Aug 2016; status: completed.
02
Drugs
ledipasvirsofosbuvir
03
Conditions
chronic hepatitis C (CHC)
Beyond the preview
Go deeper on CTR20160150.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160150.